<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE315nnn/GSE315101/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species> Mus musculus</species><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315101</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Soluble DLK1 secreted by telomere-shortening-induced senescent microglia impairs oligodendrocyte functions and alters neuronal activity [DLK1_snRNA-seq]</name><description>Aging is a predominant risk factor of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Here, we investigated the impact of telomere shortening, a physiological hallmark of aging, on brain function. Telomere-shortened mice exhibited cognitive decline and exacerbated lipofuscinosis, accompanied by the emergence of senescent microglia with a senescence-associated secretory phenotype and oligodendrocyte lineage cells with impaired maturation. Using iPSC-derived microglia with shortened telomeres, we identified DLK1 as a novel senescence-associated ligand secreted by senescent microglia. Elevated soluble DLK1 was detected in the cerebrospinal fluid of both telomere-shortened and physiologically aged mice, and this increase was abolished by microglial depletion, confirming its microglial origin. Functionally, AAV-mediated expression of sDLK1 in mouse brains induced hypomyelination and disrupted oligodendrocyte differentiation in vivo. In human iPSC-derived systems, sDLK1 impaired late-stage oligodendrocyte maturation and disrupted neuronal calcium signaling. Together, these findings establish replicative microglial senescence as a pathological feature of telomere shortening and identify sDLK1 as one key effector linking senescent microglia to oligodendrocyte dysfunction and neuronal dysregulation during brain aging.</description><dates><publication>2026/07/09</publication></dates><accession>GSE315101</accession><cross_references><GSM>GSM9421189</GSM><GSM>GSM9421188</GSM><GSM>GSM9421187</GSM><GSM>GSM9421186</GSM><GSM>GSM9421185</GSM><GSM>GSM9421184</GSM><GSM>GSM9421183</GSM><GSM>GSM9421182</GSM><GSM>GSM9421181</GSM><GSM>GSM9421180</GSM><GSM>GSM9421179</GSM><GSM>GSM9421178</GSM><GSM>GSM9421177</GSM><GSM>GSM9421176</GSM><GSM>GSM9421175</GSM><GSM>GSM9421174</GSM><GSM>GSM9421173</GSM><GSM>GSM9421195</GSM><GSM>GSM9421172</GSM><GSM>GSM9421194</GSM><GSM>GSM9421193</GSM><GSM>GSM9421192</GSM><GSM>GSM9421191</GSM><GSM>GSM9421190</GSM><GSM>GSM9867568</GSM><GSM>GSM9867569</GSM><GSM>GSM9867567</GSM><GPL>24676</GPL><GPL>24247</GPL><GSE>315101</GSE><taxon> Mus musculus</taxon><taxon>Homo sapiens</taxon></cross_references></HashMap>